The Biggest Pharmaceutical Services Company in the US Caremark Rx Announces Their Plans to Participate as a Prescription Drug Plan Sponsor
Research and Markets (researchandmarkets. com/reports/c31812) has announced the addition of Caremark Rx Business Intelligence Report to their offering.
Dublin (PRWEB) January 30, 2006
Research and Markets (http://www. researchandmarkets. com/reports/c31812 (http://www. researchandmarkets. com/reports/c31812)) has announced the addition of Caremark Rx Business Intelligence Report to their offering.
Caremark is one of the largest pharmaceutical services companies in the U. S., with net revenue of approximately $25.8 billion (including approximately $4.6 billion of retail copayments) in 2004. Caremark’s customers are primarily sponsors of health benefit plans (employers, unions, government employee groups, insurance companies and managed care organizations) and individuals located throughout the United States.
Caremark dispenses pharmaceuticals to eligible participants in benefit plans maintained by its customers and utilizes its information systems to perform safety checks, drug interaction screening and generic substitution. During the year ended December 31, 2004, Caremark managed over 484 million prescriptions for individuals from over 2,000 organizations. Caremark’s pharmaceutical services are generally referred to as pharmacy benefit management (“PBM”) services and involve the design and administration of programs aimed at reducing the costs and improving the safety, effectiveness and convenience of prescription drug use. Caremark generates substantially all of its net revenue from dispensing prescription drugs to individuals who participate in benefit plans maintained by its customers. Caremark’s PBM customers generally enter into integrated pharmacy benefit management contracts with the company.
Caremark operates a national retail pharmacy network with over 60,000 participating pharmacies, seven mail service pharmacies, the industrys only FDA-regulated repackaging plant and 21 licensed specialty pharmacies for delivery of advanced medications to individuals with chronic or genetic diseases and disorders. During 2004, Caremark processed approximately 43 million prescriptions through its mail service pharmacies and processed approximately 441 million retail pharmacy claims. Caremark Rx, announced in September 2005 that it has received approval from the Centers for Medicare and Medicaid Services (CMS) to participate as a prescription drug plan sponsor (PDP).
This Business Intelligence Report provides the information and analysis you need on Caremark Rx to gain an understanding of what makes the company one of the leading pharmacy benefit managers and specialty pharmaceutical distributors in the country. The BusIntell Report includes the following sections: Industry Overview/Trends, Company Overview, Corporate Strategy, Internet Activities, Company Executives, Financial and Statistical Information, detailed Lines of Business, Customers and Sources.
Summary
Our BusIntell Report provides the information and analysis you need on Caremark Rx to gain an understanding of what makes the company one of the leading pharmacy benefit managers and specialty pharmaceutical distributors in the country. The BusIntell Report provides the following sections: Industry Overview/Trends, Company Overview, Corporate Strategy (including Strengths/Weaknesses), Internet Activities, Company Executives, Financial and Statistical Information, detailed Lines of Business, Customers and Sources.
For more information visit http://www. researchandmarkets. com/reports/c31812 (http://www. researchandmarkets. com/reports/c31812)
Laura Wood
Senior Manager
Research and Markets
Press@researchandmarkets. com
Fax: +353 1 4100 980
###
